Deciphering Liver-Kidney Meridian Tropism and Shared Molecular Modules of Antitumor Herbal Medicines in Ovarian, Cervical, and Bladder Cancers
This study elucidates the molecular basis for the Traditional Chinese Medicine principle of "same treatment for different diseases" in ovarian, cervical, and bladder cancers by demonstrating that liver-kidney meridian-associated herbal compounds, particularly β-sitosterol and quercetin, converge on shared hub targets (AKT1, MYC, TP53, EGF, MMP9) and the PI3K-Akt pathway to regulate tumor progression and drug resistance.